It was concluded that a reduction in serum levels of TGF-β, IL-6, and IL-17 indicated the potential suppressive effects of radiation therapy and chemotherapy on Th17 cells and TGF-β-producing tumor cells in the early stages of BC patients. This evidence concerns the gene TGFB1 and neoplasm.